FibroBiologics, Inc. (FBLG)
Nasdaq: FBLG · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2023
Who runs FibroBiologics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
O'Heeron Pete
CHIEF EXECUTIVE OFFICER. First filing Feb 2024, latest May 4, 2026, 2 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
12 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Khoja Hamid | Chief Scientific Officer | Feb 2024 | Sep 15, 2026 | none |
| O'Heeron Pete | CHIEF EXECUTIVE OFFICER | Feb 2024 | May 4, 2026 | none |
| Davis Jason | Chief Financial Officer | Jun 2025 | May 4, 2026 | none |
| Garcia Ruben A | General Counsel | Mar 2024 | May 4, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Steinberg Leigh | director | Sep 2026 | Sep 1, 2026 | none |
| Rubins Kathleen Hallisey | director | Jul 2026 | Jul 16, 2026 | none |
| Cilento Richard C. Jr. | director | Feb 2024 | Jun 23, 2026 | none |
| Hoffman Robert E. | director | Feb 2024 | Jun 23, 2026 | none |
| Link Matthew | director | Feb 2024 | Jun 23, 2026 | none |
| Niklas Victoria Ninon Olivia | director | Feb 2024 | Jun 23, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.